ChemicalBook > Product Catalog >API >Circulatory system drugs >Antiarrhythmics Drugs >BRETYLIUM TOSYLATE

BRETYLIUM TOSYLATE

BRETYLIUM TOSYLATE Structure
CAS No.
61-75-6
Chemical Name:
BRETYLIUM TOSYLATE
Synonyms
ornid;asl-603;darentin;bretylan;bretylol;bretylate;darenthin;esulfonicacid;ulfonicacid(1:1);BretyliuM p-Tolu
CBNumber:
CB5239348
Molecular Formula:
C18H24BrNO3S
Molecular Weight:
414.36
MOL File:
61-75-6.mol
Modify Date:
2023/6/8 9:03:01

BRETYLIUM TOSYLATE Properties

Melting point 97-99°
storage temp. Inert atmosphere,Room Temperature
solubility H2O: soluble50mg/mL
form Solid
color white
InChIKey KVWNWTZZBKCOPM-UHFFFAOYSA-M

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302+H312+H332
Precautionary statements  P261-P280-P301+P312+P330
Hazard Codes  Xn
Risk Statements  20/21/22
Safety Statements  36
RTECS  BO9450000
HS Code  2923900100
Toxicity LD50 in mice (mg/kg): 400 orally; 250 i.m. (Goldenthal)
NFPA 704
0
3 0

BRETYLIUM TOSYLATE Chemical Properties,Uses,Production

Chemical Properties

White Solid

Uses

Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade. Bretylium tosylate is a class III antiarrhythmic agent and a competitive inhibitor of acetylcholinesterase.

Definition

ChEBI: The tosylate salt of bretylium. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibril ation.

General Description

Bretylium tosylate, (o-bromobenzyl)ethyl dimethylammonium p-toluenesulfonate(Bretylol), is an extremely bitter, white, crystalline powder.The chemical is freely soluble in water and alcohol.Bretylium tosylate is an adrenergic neuronal-blockingagent that accumulates selectively in the neurons anddisplaces norepinephrine. Because of this property,bretylium was used initially, under the trade name ofDarenthin, as an antihypertensive agent. It caused posturaldecrease in arterial pressure. This use was discontinuedbecause of the rapid development of tolerance, erratic oralabsorption of the quaternary ammonium compound, andpersistent pain in the parotid gland on prolonged therapy.

Clinical Use

Currently, bretylium is reserved for use in ventriculararrhythmias that are resistant to other therapy. Bretyliumdoes not suppress phase 4 depolarization, a common actionof other antiarrhythmic agents. It prolongs the effectiverefractory period relative to the action potential durationbut does not affect conduction time and is categorized asa class III antiarrhythmic agent. Because bretylium doesnot have properties similar to those of the other antiarrhythmicagents, it has been suggested that its action is aresult of its adrenergic neuronal-blocking properties; theantiarrhythmic properties of the drug, however, are notaffected by administration of reserpine. Bretylium is also alocal anesthetic, but it has not been possible to demonstratesuch an effect on atria of experimental animals, except atvery high concentrations. Therefore, the precise mechanismof the antiarrhythmic action of bretylium remains tobe resolved.

Side effects

The major adverse effect associated with bretylium tosylate is hypotension, including orthostatic hypotension, which may be very severe.

BRETYLIUM TOSYLATE Preparation Products And Raw materials

Raw materials

chevron_left

1of2

chevron_right

Preparation Products

Global( 96)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
OCEAN TRADING CORPORATION +91(22) 24921669 New Delhi, India 6211 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
Career Henan Chemica Co +86-0371-86658258 +8613203830695 China 30253 58 Inquiry
Shaanxi Dideu Medichem Co. Ltd +86-029-89586680 +86-18192503167 China 9030 58 Inquiry
Finetech Industry Limited +86-27-87465837 +8618971612321 China 9626 58 Inquiry
Dayang Chem (Hangzhou) Co.,Ltd. 571-88938639 +8617705817739 China 52861 58 Inquiry
Alfa Chemistry +1-5166625404 United States 21317 58 Inquiry
(o-bromobenzyl)ethyldimethyl-ammoniup-toluenesulfonate 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium4-methylbenzenesulfonate 2-bromo-n-ethyl-n,n-dimethyl-benzenemethanaminiusaltwith4-methylbenzen darentin dimethylethyl-o-bromobenzylammonium-p-toluenesulphonate esulfonicacid n-ethyl-n-o-bromobenzyl-n,n-dimethylammoniumtosylate ornid ulfonicacid(1:1) Bretylium Tosylate (200 mg) BretyliuM p-Tolu N-(2-BroMobenzyl)-N,N-diMethylethanaMiniuM 4-Methylbenzenesulfonate BretyliuM Tosylate USP 2-bromo-n-ethyl-n,n-dimethyl-benzenemethanaminiusaltwith4-methylbenzenes asl-603 bretylan bretylate bretyliump-toluenesulfonate Bretyliumtosilate bretylol darenthin [O-BROMOBENZYL]ETHYLDIMETHYL-AMMONIUM P-TOLUENESULFONATE BRETYLIUM TOSYLATE BRETYLIUM TOSYLATE ADRENERGIC NEURON BLO BRETYLIUM TOSYLATE, PHARMA (2-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate Bretyliume tosylate Retylium tosylate (2-bromobenzyl)-ethyl-dimethyl-ammonium (2-bromophenyl)methyl-ethyl-dimethylazanium (2-bromophenyl)methyl-ethyl-dimethyl-azanium 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium Bretylium Tosylate (1076352) BRETYLIUM TOSYLATE USP/EP/BP inhibit,Inhibitor,Bretylium,Bretylium tosylate 61-75-6 C18H24BrNO3S C18H24BO3RnS C11H17BrNC7H7O3S Amines Aromatics Intermediates & Fine Chemicals Pharmaceuticals Sulfur & Selenium Compounds